MediciNova, Zhejiang Announce Execution Of China JV To Develop Astma Drug – RTT News

MediciNova, Zhejiang Announce Execution Of China JV To Develop Astma Drug
RTT News
(RTTNews) – MediciNova Inc. (MNOV: News ) and Zhejiang Medicine Co., Ltd. Wednesday announced the execution of an agreement for the formation of a Joint Venture to develop and commercialize MediciNova's asthma drug MN-221 in China.
Chinese Joint Venture CompletedMarketWatch (press release)

all 4 news articles »

View full post on asthma – Google News